Role of Tofisopam in Post COVID Neuro-psychiatric Sequelae: A Case Series.

Autor:	Pattnaik, Jigyansa ipsita, Deepthi R. A., Dua, Shivani, Padhan, Prasanta, Ravan, Jayaprakash Russell
Předmět:	COVID-19 CATATONIA DISEASE complications VIRAL encephalitis SEROTONIN syndrome COVID-19 pandemic
Zdroj:	Indian Journal of Psychological Medicine; Mar2021, Vol. 43 Issue 2, p174-176, 3p
Abstrakt:	However, past outbreaks of COVID have shown that the neuropsychiatric symptoms arising out of the viral infection can add significantly to the health burden and quality of life.7,8 Thus, it becomes prudent to provide interventions for the neuropsychiatric symptoms as well. Tofisopam has an anxiolytic effect in anxiety and depression, without sedative and muscle relaxant side-effects, has anti-amnestic properties, and works for both positive and negative symptoms of psychosis. Although India reports the second- highest number of COVID-19 cases, the recovery rate stands at 93%.1,2 Those who recover from COVID-19 report ongoing respiratory, neurological, and psychiatric symptoms. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.